A pioneering research group at Yonsei University College of Medicine led by Jin Woo Chang, MD, PhD, published a new study showing the successful use of focused ultrasound to treat depression.
In the second blog in a three-part series, Foundation Chairman Neal F. Kassell, MD, and Koch Disruptive Technologies' Chase Koch assess the state of the field, their partnership, and what's next.
The Foundation’s FUS Partners program is poised to take a more holistic approach toward the ever-adjusting needs of key stakeholders in the focused ultrasound community.
We received a record-setting 245 abstracts for the Foundation’s 2020 meeting. The review and selection process is underway, and acceptance notifications will be sent in late August.
Neurologist Prof. José Obeso has built a large research and clinical practice centered on using focused ultrasound to halt the progression of Parkinson’s and other brain diseases.
Scientific Programs Manager Kelsie Timbie, PhD, discusses the blood-brain barrier and how focused ultrasound can be used to temporarily and reversibly open it.
Monday, August 3, is the new deadline to apply for this annual $75,000 award that recognizes a promising researcher using focused ultrasound to study cancer.
On July 23, the International Society for Therapeutic Ultrasound (ISTU) hosted a webinar by Alfred Yu, PhD, featuring an in-depth look at how he studies the mechanisms behind sonoporation.
On Tuesday, September 15, the Breast Cancer Alliance’s “Hot Topics in Breast Cancer” symposium will address new challenges of COVID-19, treatment advances, and stress and diet with regard to prevention and recovery.
Toronto-based Profound Medical has closed an offering of common shares and will use the proceeds in part to continue development and commercialization of its TULSA-PRO® and Sonalleve® devices globally.
